Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension

Alcon

Status and phase: Completed; Phase 4

Conditions: Pigment Dispersion Glaucoma; Ocular Hypertension; Primary Open-angle Glaucoma

Treatments: Drug: Brinzolamide 1% added to Travoprost 0.004%

Study type: Interventional

Funder types: Industry

Identifiers

NCT00372827

CM-03-06

Details and patient eligibility

About

The purpose of the study is to compare the efficacy and safety of Timolol 0.5% solution to Brinzolamide 1% each given twice daily when added to Travoprost 0.004% given each evening.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are treated with any prostaglandin analogue monotherapy (excluding unoprostone) and who have an intraocular pressure between 19 and 32 mmHg at 08:00 hours.

Exclusion criteria

• Under 18 years

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind